Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis

Rheumatology International

Volumn 33, Issue 2, 2013, Pages 341-346

  Kazakova, Maria ^a   Batalov, Anastas ^a   Deneva, Tanya ^a   Mateva, Nonka ^a   Kolarov, Zlatimir ^b   Sarafian, Victoria ^a  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Joint sonography; Rheumatoid arthritis; YKL 40

Indexed keywords

C REACTIVE PROTEIN; GLYCOPROTEIN GP 39; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL;

ADIPOKINES; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; LECTINS; MALE; MIDDLE AGED; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 84873998768     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2387-3     Document Type: Article

References (32)

1. Johansen JS (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53:172-209
2. Rehli M, Krause SW, Andreesen R (1997) Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43:221-225
3. Roslind A, Johansen JS (2009) YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 511:159-184
4. Bojesen SE, Johansen JS, Nostegaard BG (2011) Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta 412:709-712
5. Güngen G, Ardic F, FιndIkoǧlu G, Rota S (2011) The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis. Rheumatol Int 31:1-10
6. Zyvanovic S, Rackov LP, Vojvodic D, Vucetic D (2009) Human cartilage glycoprotein 39-biomarker of joint damage in knee osteoarthritis. Int Orthop 33:1165-1170
7. Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sørensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211:589-595
8. Letuve S, Kozhich A, Arouche N, Grandsaigne M, Reed J, Dombret MC, Kiener PA, Aubier M, Coyle AJ, Pretolani M (2008) YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 181:5167-5173
9. Rondbjerg A, Omerovic E, Vestergaard H (2011) YKL-40 levels are independently associated with albuminuria in type 2. Cardiovasc Diabetol 10:54. doi: 10.1186/1475-2840-10-54
10. Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ (2002) High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 95:267-274
11. Yamac D, Ozturk B, Coskun U, Tekin E, Sancak B, Yildiz R, Atalay C (2008) Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Adv Ther 25:801-809. doi: 10.1007/s12325-008-0082-2
12. Hogdall E, Johansen JS (2009) YKL-40 tissue expression and plasma levels in patients with ovarian cancer. Biomed Central Cancer 9:8. doi: 10.1186/1471-2407-9-8
13. Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F, Ozkan A (2008) Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol 26:47-52
14. Tanwar MK, Gilbert MR, Holland EC (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62:4364-4368
15. Peltomaa R, Paimela L, Harvey S, Helve T, Leirisalo-Repo M (2001) Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new biomarker for disease activity. Rheumatol Int 20:192-196
16. Mandl P, Naredo E, Wakefield RG, Conaghan PG, D'agostino MA, OMERACT Ultrasound Task Force (2011) A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 38:2055-2062
17. Schmidt WA, Schmidt H, Schicke B, Cromlica-Ichle E (2004) Standard reference values for musculoskeletal ultrasonography. Ann Rheum Dis 63:988-994
18. Wakefield RJ, Gibbon WW, Conaghan PG, O'Connor P, McGonagle D, Pease C, Green MJ, Veale DJ, Isaacs JD, Emery P (2000) The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 43:2762-2770
19. Naredo E, Bonilla G, Gamero F (2005) Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical avaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 64:375-381
20. Fox DA (1997) The role of T cells in the immunopathogenesis of rheumatoid arthritis. New perspectives. Arthritis Rheum 40:598-609
21. Emery P, Gough A, Salmon M, Devlin J (1993) Medical management of rheumatoid arthritis. BMJ 307:425-428
22. Kirwan JR, Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 333:142-147
23. Johansen JS, Jensen HS, Price PA (1993) A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 32:949-955
24. Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Østergaard M, Østergaard K, Løvgreen-Nielsen P, Sonne-Holm S, Lorenzen I (2001) Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr Cartil 9:203-214
25. Knudsen LS, Hetland ML, Johansen JS, Skjodt H, Peters ND, Colic A, Grau K, Nielsen NJ, Ostergaard M (2009) Changes in plasma IL-6, plasma VEGF and serum YKL-40 during treatment with etanercept and methotrexate or etanercept alone in patients with active rheumatoid arthritis despite methotrexate therapy. Biomarker Insights 4:91-95
26. Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M (1997) Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 237:46-54
27. Volck B, Price PA, Johansen JS, Sørensen O, Benfield T, Calafat J, Nielsen HJ, Borregaard N (1998) YKL-40, a mammalian member of the bacterial chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Phys 110:351-360
28. Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803-25810
29. Takahashi M, Naito K, Abe M, Sawada T, Nagano A (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 6:208-212
30. Syversen SW, Goll GL, Heijde D, Landeve R, Lie BA, Odegard S, Uhlig T, Gaarder PI, Kvien TK (2009) Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 69:345-351. doi: 10.1136/ard.2009.113092
31. Weidekamm C, Koller M, Weber M, Kainberger F (2003) Diagnostic value of high-resolution B-mode and Doppler sonography for imaging of hand and finger joints in rheumatoid arthritis. Arthritis Rheum 48:325-333
32. Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R (2011) Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem 286:15332-15343